About Resilience Therapeutics

About company

Resilience Therapeutics is an operator of a drug discovery company intended to focus on developing small molecule therapeutics for psychiatric conditions. The company develops therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders. Its drug discovery engine focuses on developing therapeutics that provide both symptom relief and potential disease modification for PTSD and other Stress-Related Disorders, providing medical practitioners with therapeutics that provide both symptom relief and potential disease modification for anxiety and trauma-related disorders. Founded in 2014, Resilience Therapeutics is headquartered in Boston, Massachusetts.